Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21062137 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
Condition: Hypertension
Interventions: Drug: Aliskiren;   Drug: Valsartan;   Drug: Hydrochlorothiazide (HCTZ)

Indicates status has not been verified in more than two years